limonin has been researched along with 3,7-dioxolanosta-8,24-dien-26-oic acid in 1 studies
| Studies (limonin) | Trials (limonin) | Recent Studies (post-2010) (limonin) | Studies (3,7-dioxolanosta-8,24-dien-26-oic acid) | Trials (3,7-dioxolanosta-8,24-dien-26-oic acid) | Recent Studies (post-2010) (3,7-dioxolanosta-8,24-dien-26-oic acid) |
|---|---|---|---|---|---|
| 159 | 0 | 106 | 6 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banik, NL; Das, A; Giglio, P; Holden, CA; Jaboin, J; Lee, P; Lindhorst, SM; Miller, R; Patel, SJ; Raizer, JJ; Vandergrift, WA; Varma, AK | 1 |
1 other study(ies) available for limonin and 3,7-dioxolanosta-8,24-dien-26-oic acid
| Article | Year |
|---|---|
A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt/β-catenin signaling pathway.
Topics: Apoptosis; Catechols; Cell Line, Tumor; DNA Fragmentation; Fatty Alcohols; Flavones; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heptanoic Acids; Humans; Lanosterol; Limonins; Meningioma; Sesquiterpenes; Triterpenes; Wnt Signaling Pathway | 2015 |